HT
ACAD icon

HAP Trading’s Acadia Pharmaceuticals ACAD Stock Holding History

HAP Trading’s Portfolio ACAD Stock Details ACAD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		$10.5K Buy
+50,000
New +$1.18M ﹤0.01% 764
2021
Q3 		– Sell
-11,900
Closed -$28K – 2395
2021
Q2 		$28K Sell
11,900
-7,600
-39% -$172K ﹤0.01% 1702
2021
Q1 		$62K Buy
+19,500
New +$858K ﹤0.01% 1105
2020
Q1 		– Sell
-13,100
Closed -$57K – 1176
2019
Q4 		$57K Buy
+13,100
New +$570K ﹤0.01% 684
2019
Q2 		– Sell
-12,900
Closed -$27K – 1093
2019
Q1 		$27K Sell
12,900
-7,100
-36% -$166K ﹤0.01% 770
2018
Q4 		$5K Buy
20,000
+7,500
+60% +$146K ﹤0.01% 1010
2018
Q3 		$18K Sell
12,500
-1,600
-11% -$25.2K ﹤0.01% 774
2018
Q2 		$7K Buy
+14,100
New +$251K ﹤0.01% 902
2017
Q2 		– Sell
-11,000
Closed -$8K – 925
2017
Q1 		$8K Sell
11,000
-86,300
-89% -$3.05M ﹤0.01% 928
2016
Q4 		$67K Buy
97,300
+87,300
+873% +$2.31M ﹤0.01% 619
2016
Q3 		$2K Buy
+10,000
New +$339K ﹤0.01% 1069
2016
Q2 		– Sell
-543,200
Closed -$698K – 888
2016
Q1 		$698K Buy
543,200
+532,300
+4,883% +$11.6M 0.05% 258
2015
Q4 		$14K Buy
+10,900
New +$384K ﹤0.01% 756

Other funds holding ACAD

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return

HAP Trading's ACAD Position: Q4 2021 in Review

HAP Trading sold out of Acadia Pharmaceuticals (ACAD) in Q4 2021, closing a stake of 15,097 shares — an estimated $251K sold.

HAP Trading first reported a position in ACAD in Q3 2013 and held it in 5 quarters. The position peaked at $1.38M in Q1 2016. 247 funds tracked by Wall St. Rank hold ACAD as of Q4 2021.

  • HAP Trading reported no remaining Acadia Pharmaceuticals position as of Q4 2021 after selling out during the quarter.
  • HAP Trading sold 15,097 Acadia Pharmaceuticals shares in Q4 2021, an estimated $251K.
  • HAP Trading first reported a position in Acadia Pharmaceuticals in Q3 2013 and held it in 5 quarters.
  • HAP Trading's Acadia Pharmaceuticals position peaked at $1.38M in Q1 2016.
  • 247 funds tracked by Wall St. Rank held Acadia Pharmaceuticals as of Q4 2021.

Based on HAP Trading's 13F filing for Q4 2021, filed 14 Feb 2022.